BALAXI
Balaxi Pharmaceuticals Limited
Pharmaceuticals
Share price
₹22
Market cap
₹146 Cr
1Y return
▼ 53%
An IPR-based pharmaceutical company engaged in the production, stocking, and distribution of branded and generic medicines across India. Balaxi Pharma manufactures a diverse portfolio of pharmaceutical products catering to various therapeutic segments and medical needs. The company distinguishes itself through its focus on developing proprietary formulations while maintaining quality standards in manufacturing, regulatory compliance, and supply chain operations across domestic markets.
Investors holding Balaxi Pharmaceuticals Limited
2.54%
Latest move
RGSL InvestmentIncreased
RGSL Investment bought 5,22,340 shares of Balaxi Pharmaceuticals for ₹0.92 Cr at ₹17.68 apiece in a bulk deal on March 24, 2026.
Sign in to read more
Whales made 1 more move in Balaxi Pharmaceuticals Limited
Sign in to see who is buying and selling.
Sign in to find out